Treatment of primary acute myelogenous leukemia (AML) specimens with parthenolide (PTL)

ABSTRACT: The effects of 7.5 micromolar parthenolide (PTL) were assessed on primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients. Keywords: drug response, gene expression search agent

ORGANISM(S): Homo sapiens

PROVIDER: GSE7538 | GEO | 2008/02/27

SECONDARY ACCESSION(S): PRJNA99367

REPOSITORIES: GEO